Willie Quinn | Chief Financial Officer & Senior Vice President, Corporate Development |
Dayton Misfeldt | Interim Chief Executive Officer |
Judy Fox | Chief Scientific Officer |
Par Hyare | Senior Vice President Commercial |
Deepali Suri | Vice President, Clinical Operations |
Justin Kim | Oppenheimer |
Kenneth Atkins | Cowen |
Good afternoon, ladies and gentlemen, and welcome to the Q3 2019 Sunesis Pharmaceuticals Inc. Earnings Conference Call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions]